| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |